Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:04 AM
Ignite Modification Date:
2025-12-25 @ 3:04 AM
NCT ID:
NCT04293133
Eligibility Criteria:
Inclusion Criteria:
* Patients having a documented history of classical CAH.
Exclusion Criteria:
* Patients with non classical CAH.
* Patients treated with growth hormone.
* Chronic use of medications unrelated to CAH which may affect growth like immunosuppressive drugs like azathioprine and drugs that affect growth hormone release like octreotide, pegvisomant, bromocriptine and cabergoline.
* Other chronic diseases that may affect growth like heart disease, inflammatory bowel disease and renal disease.
* Other causes of adrenal insufficiency.
Sex:
ALL
Maximum Age:
18 Years
Study:
NCT04293133
Study Brief:
Protocol Section:
NCT04293133